Carbon Health raises $350M to further expansion plans
After more than doubling its patient volumes during the pandemic, Carbon Health raised funding to further its growth plans. The company said it plans to open 1,500 clinics by 2025.
Anthem, K Health, Blackstone launch digital health company
The new joint venture will bring K Health's artificial intelligence-driven technology to the consumer, employer and insurer markets. The solution enables patients to understand their symptoms and connect with a doctor if needed.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Imago raises $80M to further studies of its treatment for blood and bone-marrow disorders
The San Francisco-based company aims to complete at least one Phase III study by 2025, and it is weighing an IPO next year to fund more.
Blackstone’s $4.7B acquisition of Ancestry raises privacy questions
Ancestry, which grew from a genealogy tracking tool to offering DNA tests for a number of healthconditions, reached a deal to be acquired by Blackstone for $4.7 billion. But privacy advocates have raised concerns over the deal — namely, what would happen to users’ health data?
Alnylam gets $2B funding boost from Blackstone to develop drug pipeline
A key component of the deal includes a $1 billion purchase of 50% of royalties owed to Alnylam on sales of inclisiran, a drug for hypercholesterolemia that works by gene silencing. The company's CEO said uncertainty and volatility due to Covid-19 meant the timing was right for the deal.
Novartis, Blackstone launch Anthos Therapeutics to develop cardiovascular drugs
Blackstone is investing $250 million, while Novartis is licensing MAA868, a drug for patients who are underserved by existing anti-coagulant drugs.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Blackstone entrepreneur mentoring program for non-business majors comes to Philadelphia
In the latest startup news from Philadelphia, private equity giant Blackstone’s philanthropic arm is expanding its LaunchPad program to the city to teach university students how to start their own businesses. There has been a push at several universities to encourage a culture of entrepreneurship. This one seeks to help universities grow entrepreneurship beyond business […]